Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOCRATES-AF: Semaglutide for Atrial Fibrillation
NCT04885634Phase 3Withdrawn
- Start
- Oct 2022
- Primary completion
- Jan 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of semaglutide in Atrial fibrillation (AFib). Planned start Oct 2022; status: withdrawn.
02
Drugs
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04885634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885634.